Post-Traumatic Stress Disorders Clinical Trials

People with post-traumatic stress disorder are asked to participate in a research study being conducted by Montefiore Medical Center.

Are you one of the proud who has served or is currently serving your country or community? Have you also experienced a traumatic event that has caused lingering effects like anxiety, insomnia or nightmares? If so, you may want to volunteer for our clinical research study of an investigational new ...

Interventional, randomised, double-blind, parallel-group, placebo-controlled, flexible-dose study to evaluate the efficacy of brexpiprazole as adjunctive treatment to paroxetine or sertraline on PTSD symptoms.

We want to see if couple's-based therapy reduces Post-Traumatic Stress Disorder (PTSD) symptoms and improves relationships with partners and children.

The goal of this study is to assess whether Regulation Focused Psychotherapy for Children (RFP-C) helps children and their families. This is a new treatment approach. Most treatment approaches for children with disruptive behaviors focus on coaching parents. RFP-C focuses on increasing the child or adolescent’s ability to regulate difficult ...

A Phase 2, Multicenter, Randomized, Double-blind, Placebo- and Active-controlled Trial of Brexpiprazole (1-3 mg/day) as Monotherapy or as Combination Therapy in the Treatment of Adults with Post-traumatic Stress Disorder

To evaluate the safety, efficacy and tolerability of brexpiprazole (with placebo) as monotherapy or combination therapy (Zoloft) in adults with PTSD.

Primary: To evaluate the efficacy of brexpiprazole as monotherapy or as combination treatment with Zoloft (sertraline) in adult subjects with PTSD. Secondary: To evaluate the safety and tolerability of brexpiprazole 1 to 3 mg/day as monotherapy or as combination treatment with Zoloft (sertraline) in adult subjects with PTSD.

Are you living with PTSD? Meridien Research is seeking research volunteers for a clinical study of PTSD.

This study will evaluate the efficacy of cyclobenzaprine in the treatment of military-related PTSD. The study is randomized and double-blind, meaning both the participant and the tester are unaware which group is receiving the experimental and placebo treatments. The study will last approximately 12 weeks. Participants take the study drug ...